Letter from the President:
On behalf of the Organising and Scientific Committees it is our great pleasure to welcome you to the 1st conference of the European Federation for Exploratory Medicines Development (EUFEMED), to be held from May 18 – 19, 2017 in London, United Kingdom.
This conference is the result of a continued joint effort of the founding associations of EUFEMED: BAPU (Belgium), Club Phase 1 (France), AGAH (Germany) and AHPPI (United Kingdom). Indeed, after organising successful joint meetings in Berlin (2011), Nice (2013) and Brussels (2015) we are proud to present to you this exciting scientific program.
Following the tradition of previous conferences, this 2-day meeting provides an excellent opportunity to hear about recent advances in early clinical drug development. To that end a mixture is offered of focused scientific sessions, interactive workshops and open forum panel discussions. Being aware of the importance of safety in exploratory medicines development, the focus of the 2017 meeting is on innovation and risk management in early phase clinical trials.
A 1-day preconference workshop takes place on 17 May and is dedicated to practical aspects of assessing and mitigating risk in early clinical drug development.
It is our intention to offer a stimulating scientific atmosphere in which you can meet old colleagues and make new friends, inspired by the lively city of London.
We welcome you to EUFEMED 2017!